Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxytocin Treatment for Chronic Pain in Hypermobile Ehlers-Danlos Syndrome

NCT05405257 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT05405257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05405257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxytocin Treatment for Chronic Pain in Hypermobile Ehlers-Danlos Syndrome
Lead sponsor
Baylor College of Medicine
Phase
Phase 1/2
Overall status
Terminated
Start date
May 13, 2022
Completion date
March 11, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypermobile ehlers-danlos syndrome, pain assessment